We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$5.51B
Cap. Flow %
1.92%
Top 10 Hldgs %
12.98%
Holding
8,864
New
807
Increased
4,306
Reduced
2,683
Closed
688

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.31%
2 Technology 9.89%
3 Financials 7.42%
4 Healthcare 6.84%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVOL
7251
DELISTED
Evolving Systems, Inc.
EVOL
$11K ﹤0.01%
12,466
+11,215
+896% +$11.5K
AMBO
7252
Ambow Education Holding
AMBO
$6.06M
$10K ﹤0.01%
516
+48
+10% +$756
ANGI icon
7253
Angi Inc
ANGI
$216M
$10K ﹤0.01%
120
-601
-83% -$44.9K
FRMM
7254
Forum Markets
FRMM
$68.4M
– –
0
– –
BCDA icon
7255
BioCardia
BCDA
$16.2M
$10K ﹤0.01%
+190
New +$11.2K
BLNK icon
7256
Blink Charging
BLNK
$82M
$10K ﹤0.01%
5,254
+856
+19% +$1.78K
BUL icon
7257
Pacer US Cash Cows Growth ETF
BUL
$135M
$10K ﹤0.01%
395
-6
-1% -$150
CDTX
7258
DELISTED
Cidara Therapeutics
CDTX
$10K ﹤0.01%
132
-321
-71% -$14.7K
COHN icon
7259
Cohen & Co
COHN
$33.1M
$10K ﹤0.01%
2,467
+1,793
+266% +$6.98K
CPHI icon
7260
China Pharma Holdings
CPHI
$31.4M
$10K ﹤0.01%
82
+73
+811% +$9K
CPSS icon
7261
Consumer Portfolio Services
CPSS
$204M
$10K ﹤0.01%
3,071
-318
-9% -$1.07K
CVV icon
7262
CVD Equipment Corp
CVV
$30.7M
$10K ﹤0.01%
2,944
+521
+22% +$1.81K
EAGG icon
7263
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.97B
$10K ﹤0.01%
+183
New +$9.86K
EFAS icon
7264
Global X MSCI SuperDividend EAFE ETF
EFAS
$62.2M
$10K ﹤0.01%
587
-1,000
-63% -$16K
FPH icon
7265
Five Point Holdings
FPH
$340M
$10K ﹤0.01%
1,423
-4,171
-75% -$28.5K
FVAL icon
7266
Fidelity Value Factor ETF
FVAL
$1.37B
$10K ﹤0.01%
261
-607
-70% -$22K
GORV
7267
DELISTED
Lazydays
GORV
$10K ﹤0.01%
78
+51
+189% +$6.62K
HHS icon
7268
Harte-Hanks
HHS
$34.5M
$10K ﹤0.01%
2,835
-332
-10% -$986
IHRT icon
7269
iHeartMedia
IHRT
$354M
$10K ﹤0.01%
+571
New +$8.65K
JPME icon
7270
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$478M
$10K ﹤0.01%
139
-1,943
-93% -$132K
MOTO icon
7271
Guinness Atkinson Smart Transportation & Technology ETF
MOTO
$12.2M
$10K ﹤0.01%
+392
New +$9.98K
NNDM
7272
Nano Dimension
NNDM
$333M
$10K ﹤0.01%
3,991
+1,191
+43% +$3.63K
SCPH
7273
DELISTED
scPharmaceuticals
SCPH
$10K ﹤0.01%
+1,781
New +$9.11K
SIF icon
7274
SIFCO Industries
SIF
$135M
$10K ﹤0.01%
2,594
-11,064
-81% -$31.3K
SLE icon
7275
Super League Enterprise
SLE
$241M
– –
0
– –

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 807 new, 4,306 increased, 2,683 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 807 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.